| 000 | 01891 a2200601 4500 | ||
|---|---|---|---|
| 005 | 20250518082835.0 | ||
| 264 | 0 | _c20210514 | |
| 008 | 202105s 0 0 eng d | ||
| 022 | _a1365-2133 | ||
| 024 | 7 |
_a10.1111/bjd.18898 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSimpson, E L | |
| 245 | 0 | 0 |
_aBaricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. _h[electronic resource] |
| 260 |
_bThe British journal of dermatology _c08 2020 |
||
| 300 |
_a242-255 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdrenal Cortex Hormones |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 | _aAzetidines |
| 650 | 0 | 4 |
_aDermatitis, Atopic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPurines |
| 650 | 0 | 4 | _aPyrazoles |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSulfonamides |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLacour, J-P | |
| 700 | 1 | _aSpelman, L | |
| 700 | 1 | _aGalimberti, R | |
| 700 | 1 | _aEichenfield, L F | |
| 700 | 1 | _aBissonnette, R | |
| 700 | 1 | _aKing, B A | |
| 700 | 1 | _aThyssen, J P | |
| 700 | 1 | _aSilverberg, J I | |
| 700 | 1 | _aBieber, T | |
| 700 | 1 | _aKabashima, K | |
| 700 | 1 | _aTsunemi, Y | |
| 700 | 1 | _aCostanzo, A | |
| 700 | 1 | _aGuttman-Yassky, E | |
| 700 | 1 | _aBeck, L A | |
| 700 | 1 | _aJanes, J M | |
| 700 | 1 | _aDeLozier, A M | |
| 700 | 1 | _aGamalo, M | |
| 700 | 1 | _aBrinker, D R | |
| 700 | 1 | _aCardillo, T | |
| 700 | 1 | _aNunes, F P | |
| 700 | 1 | _aPaller, A S | |
| 700 | 1 | _aWollenberg, A | |
| 700 | 1 | _aReich, K | |
| 773 | 0 |
_tThe British journal of dermatology _gvol. 183 _gno. 2 _gp. 242-255 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bjd.18898 _zAvailable from publisher's website |
| 999 |
_c30574057 _d30574057 |
||